For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() Phillips 66PSX US · Energy · USD Current price$244.83as of Nov 19, 2026 Summary
Analyst consensusStrong Buy 3Buy 8Hold 8Strong Sell 119 analysts 3-year price (USD)Factor profileMulti-factor score 100 / 100 Market data
Business descriptionPhillips 66 (PSX) is a diversified energy manufacturing and logistics company operating across four segments: Refining, Midstream, Marketing & Specialties, and Chemicals (via its 50% joint venture in Chevron Phillips Chemical Company - CPChem). Spun off from ConocoPhillips in 2012, PSX balances volatile refining cash flows with fee-based midstream logistics and petrochemical manufacturing. Competitive moatPhillips 66 benefits from an integrated asset footprint where midstream logistics and chemical operations (CPChem) partially cushion earnings against pure refining cyclicality. CPChem leverages low-cost U.S. ethane feedstock compared to international naphtha steam crackers, gaining a distinct structural cost advantage during Middle Eastern supply constraints. Recent developments
Investment risks / red flags
Financials
Classification
|
Theme Exposure
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: PSXBusiness description
Phillips 66 (PSX) is a diversified energy manufacturing and logistics company operating across four segments: Refining, Midstream, Marketing & Specialties, and Chemicals (via its 50% joint venture in Chevron Phillips Chemical Company - CPChem). Spun off from ConocoPhillips in 2012, PSX balances volatile refining cash flows with fee-based midstream logistics and petrochemical manufacturing.
Competitive moat
Phillips 66 benefits from an integrated asset footprint where midstream logistics and chemical operations (CPChem) partially cushion earnings against pure refining cyclicality. CPChem leverages low-cost U.S. ethane feedstock compared to international naphtha steam crackers, gaining a distinct structural cost advantage during Middle Eastern supply constraints.
Recent developments
- CFRA Reaffirms Hold & Lifts Target to $299 (10/09/2026): CFRA maintains its Hold rating while raising its 12-month target to USD 299.00 (from USD 235.00), noting that shares are up 119% YTD on refining margin expansion. However, peers have rallied 162%–185% YTD, leaving PSX lagging slightly in valuation capture during this upcycle.
- Midstream Export License Relief: Regulatory concerns regarding export licensing requirements for natural gas liquids (ethane and propane to Asia) were successfully lifted, preserving long-term NGL export volume and growth prospects.
- Aggressive Debt Reduction & Buybacks: Management is accelerating share buybacks and executing a disciplined deleveraging plan following Q1 2026 market volatility, supported by strong operating cash flows (~$8B annualized).
- Chemicals Feedstock Tailwind: Disrupted naphtha shipments from the Middle East have amplified demand for U.S. ethane feedstock used by CPChem.
Investment risks / red flags
- Refining Margin Divergence: Because PSX is more diversified into midstream and chemicals, it captures less upside during pure refining margin spikes compared to pure-play refiners like VLO or MPC.
- China NGL Export Exposure: NGL export demand is sensitive to Chinese economic activity and petrochemical demand.
- Turnaround Execution: Extended facility maintenance and unexpected cost inflation could weigh on margins.
Market Data
Source: mkts.io · Nov 19, 2026, 14:00 UTC
Key Metrics
Analyst Consensus
Calendar Events
Financials
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 11.13 | $44.83B |
| +1q | 8.14 | $39.84B |
| 0y | 34.84 | $179.22B |
| +1y | 32.08 | $155.26B |
Earnings
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Nov 4, 2026 | Citigroup | main | Neutral |
| Nov 2, 2026 | Morgan Stanley | main | Overweight |
| Oct 31, 2026 | Freedom Broker | up | Hold |
| Oct 29, 2026 | Wells Fargo | main | Overweight |
| Oct 29, 2026 | Piper Sandler | main | Neutral |
| Oct 22, 2026 | TD Cowen | main | Buy |
